Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Clinical relevance of genetic polymorphisms in the human CYP2C subfamily.

Goldstein JA.

Br J Clin Pharmacol. 2001 Oct;52(4):349-55. Review.

2.
3.

[Genetic polymorphism of the CYP2C subfamily].

Chiba K.

Nihon Yakurigaku Zasshi. 1998 Jul;112(1):15-21. Review. Japanese.

PMID:
9755458
4.

Clinical significance of the cytochrome P450 2C19 genetic polymorphism.

Desta Z, Zhao X, Shin JG, Flockhart DA.

Clin Pharmacokinet. 2002;41(12):913-58. Review.

PMID:
12222994
5.

Biochemistry and molecular biology of the human CYP2C subfamily.

Goldstein JA, de Morais SM.

Pharmacogenetics. 1994 Dec;4(6):285-99. Review.

PMID:
7704034
6.
7.

Genetic polymorphism of the human cytochrome P450 2C9 gene and its clinical significance.

Wang B, Wang J, Huang SQ, Su HH, Zhou SF.

Curr Drug Metab. 2009 Sep;10(7):781-834. Review.

PMID:
19925388
8.

Impact of genetic polymorphisms in CYP2C9 and CYP2C19 on the pharmacokinetics of clinically used drugs.

Hirota T, Eguchi S, Ieiri I.

Drug Metab Pharmacokinet. 2013;28(1):28-37. Epub 2012 Nov 20. Review.

9.

The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.

de Leon J, Susce MT, Murray-Carmichael E.

Mol Diagn Ther. 2006;10(3):135-51. Review.

PMID:
16771600
10.

Genetic polymorphism of S-mephenytoin 4'-hydroxylation.

Daniel HI, Edeki TI.

Psychopharmacol Bull. 1996;32(2):219-30. Review.

PMID:
8783891
11.

Polymorphisms of human cytochrome P450 2C9 and the functional relevance.

Zhou SF, Zhou ZW, Huang M.

Toxicology. 2010 Dec 5;278(2):165-88. doi: 10.1016/j.tox.2009.08.013. Epub 2009 Aug 26. Review.

PMID:
19715737
12.
13.

Polymorphism of human cytochrome P450 enzymes and its clinical impact.

Zhou SF, Liu JP, Chowbay B.

Drug Metab Rev. 2009;41(2):89-295. doi: 10.1080/03602530902843483. Review.

PMID:
19514967
14.

Pharmacogenetics and psychopharmacotherapy.

Poolsup N, Li Wan Po A, Knight TL.

J Clin Pharm Ther. 2000 Jun;25(3):197-220. Review.

PMID:
10886465
15.

Molecular mechanisms of genetic polymorphisms of drug metabolism.

Meyer UA, Zanger UM.

Annu Rev Pharmacol Toxicol. 1997;37:269-96. Review.

PMID:
9131254
16.

Update: genetic polymorphism of drug metabolizing enzymes in humans.

Tanaka E.

J Clin Pharm Ther. 1999 Oct;24(5):323-9. Review.

PMID:
10583694
17.
18.

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

Lee CR, Goldstein JA, Pieper JA.

Pharmacogenetics. 2002 Apr;12(3):251-63. Review. Erratum in: Pharmacogenetics 2002 Jun;12(4):343.

PMID:
11927841
19.
20.

Clinical relevance of genetic polymorphisms in the human CYP2C9 gene.

Schwarz UI.

Eur J Clin Invest. 2003 Nov;33 Suppl 2:23-30. Review.

PMID:
14641553
Items per page

Supplemental Content

Write to the Help Desk